Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Cytosorbents Corp | tv505872_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - Cytosorbents Corp | tv505872_ex32-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Cytosorbents Corp | tv505872_ex31-1.htm |
| 10-Q - FORM 10-Q - Cytosorbents Corp | tv505872_10q.htm |
Exhibit 32.1
CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Phillip Chan, the President and Chief Executive Officer of CytoSorbents Corporation, hereby certify, that, to my knowledge:
| 1. | The Quarterly Report on Form 10-Q for the quarter ending September 30, 2018, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in such Quarterly Report on Form 10-Q for the quarter ending September 30, 2018, fairly presents, in all material respects, the financial condition and results of operations of CytoSorbents Corporation. |
|
Date: November 6, 2018 |
||
|
CYTOSORBENTS CORPORATION |
||
|
By: |
/s/ Phillip P. Chan |
|
| Phillip Chan | ||
| President and Chief Executive Officer | ||